908 Devices Inc. (MASS): Price and Financial Metrics
GET POWR RATINGS... FREE!
MASS Stock Price Chart Interactive Chart >
MASS Price/Volume Stats
|Current price||$40.00||52-week high||$79.60|
|Prev. close||$41.70||52-week low||$33.71|
|Day high||$43.00||Avg. volume||281,088|
|50-day MA||$45.59||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||1.09B|
908 Devices Inc. (MASS) Company Bio
908 Devices, Inc. develops measurement devices for chemical and biochemical analysis. It develops its products using mass spectrometry technology, an analytical technique for measuring the mass of charged molecules that is used in chemical analysis laboratories for applications, such as safety and security, food science, biotechnology, clinical diagnostics, and controlling industrial processes. Its products include desktops and handhelds. The company was founded by Kevin J. Knopp, Miller Scott, Steve Araiza, Andrew Bartfay, Michael Jobin, Christopher D. Brown, and Christopher J. Petty in 2012 and is headquartered in Boston, MA.
MASS Latest News Stream
|Loading, please wait...|
MASS Latest Social Stream
View Full MASS Social Stream
Latest MASS News From Around the Web
Below are the latest news stories about 908 Devices Inc that investors may wish to consider to help them evaluate MASS as an investment opportunity.
908 Devices Appoints Marcia Eisenberg, Ph.D., Chief Scientific Officer of Labcorp Diagnostics, to its Board of Directors
908 Devices (NASDAQ: MASS), a pioneer of purpose-built, handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, to serve on its Board of Directors effective immediately.
BOSTON, May 20, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will participate virtually in the upcoming William Blair 41st Annual Growth Stock Conference. 908 Devices’ management is scheduled to participate in a fireside chat on Thursday, June 3rd at 11:20 a.m. Pacific Time / 2:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: https://ir.908devices.com/news-events/events. About 908 Devices908 Devices is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s dev...
Q1 2021 Product and Service Revenue Increased More Than 100% Over Prior YearBOSTON, May 13, 2021 (GLOBE NEWSWIRE) -- 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended March 31, 2021. Recent Highlights Q1 2021 total revenue increased 39% over prior year periodIncreased the installed base to 1,427 devices with 66 devices placed during the first quarter, double the number of devices placed compared to the first quarter of 2020Deepened traction within biopharma with multiple desktop devices placed at existing customers; approximately 40% of total desktop installed base now placed across top 20 biopharma companiesAnnounced the MX908 Aero / Bluetooth ...
Biomerica Inc (NASDAQ: BMRA ) has announced that its new COVID-19 Antigen Rapid Test can now be performed with a simple, less invasive nasal swab. The test is highly portable, cost-effective, and provides results in 15 minutes versus lab-run PCR tests, taking up to three days for results. Price Action: BMRA shares closed 17.3% lower at $3.41 on Tuesday. 908 Devices Inc (NASDAQ: MASS ) has announced updates to its MX908 handheld mass spec device , including an aerosol module … Full story available on Benzinga.com
New Features Enable Detection of Aerosols and New Synthetic Drug Targets; Remote Bluetooth App Enables Rapid Data Sharing
MASS Price Returns